158 related articles for article (PubMed ID: 14631375)
21. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
González-Guerra E; Kutzner H; Rutten A; Requena L
Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
[TBL] [Abstract][Full Text] [Related]
22. Differentiating between apocrine and eccrine hidrocystoma.
Bures FA; Kotynek J
Cutis; 1982 Jun; 29(6):616, 619-20. PubMed ID: 7105836
[No Abstract] [Full Text] [Related]
23. Apocrine Papillary Hidrocystoma With Mucinous Metaplasia (Goblet Cell Type): A Case Report and Review of the Literature.
Epperson J; Bergfeld W
Am J Dermatopathol; 2023 May; 45(5):330-332. PubMed ID: 36939135
[TBL] [Abstract][Full Text] [Related]
24. Cytokeratin expression of apocrine and eccrine poromas with special reference to its expression in cuticular cells.
Yamamoto O; Hisaoka M; Yasuda H; Kasai T; Hashimoto H
J Cutan Pathol; 2000 Aug; 27(7):367-73. PubMed ID: 10917164
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous Adenomyoepithelioma: Report of a Case and Review of the Literature.
González I; Gonzalez ML; Kroh JM; Fraga GR
Am J Dermatopathol; 2016 Jul; 38(7):549-52. PubMed ID: 26981739
[TBL] [Abstract][Full Text] [Related]
26. CD10 expression in cutaneous adnexal neoplasms and a potential role for differentiating cutaneous metastatic renal cell carcinoma.
Bahrami S; Malone JC; Lear S; Martin AW
Arch Pathol Lab Med; 2006 Sep; 130(9):1315-9. PubMed ID: 16948517
[TBL] [Abstract][Full Text] [Related]
27. Malignant eccrine spiradenoma with smooth muscle cell differentiation: histological and immunohistochemical study.
Itoh T; Yamamoto N; Tokunaga M
Pathol Int; 1996 Nov; 46(11):887-93. PubMed ID: 8970199
[TBL] [Abstract][Full Text] [Related]
28. Apocrine hidrocystoma of the urethral meatus: a case report.
Taylor D; Juhl ME; Krunic AL; Sidiropoulos M; Gerami P
Acta Derm Venereol; 2015 Mar; 95(3):376-7. PubMed ID: 24978625
[No Abstract] [Full Text] [Related]
29. Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation.
Płachta I; Kleibert M; Czarnecka AM; Spałek M; Szumera-Ciećkiewicz A; Rutkowski P
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064849
[TBL] [Abstract][Full Text] [Related]
30. [Eccrine carcinoma: a diagnostic pitfall].
Moonen HPFX; Koot RAC; Hoven-Gondrie ML
Ned Tijdschr Geneeskd; 2020 Mar; 164():. PubMed ID: 32324349
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
Ansai S; Koseki S; Hozumi Y; Kondo S
Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
[TBL] [Abstract][Full Text] [Related]
32. Multiple eccrine hidrocystomas of the face.
Alfadley A; Al Aboud K; Tulba A; Mourad MM
Int J Dermatol; 2001 Feb; 40(2):125-9. PubMed ID: 11328394
[TBL] [Abstract][Full Text] [Related]
33. Pigmented hidrocystoma of the eccrine secretory coil in the vulva: clinicopathologic, immunohistochemical and ultrastructural studies.
Kamishima T; Igarashi S; Takeuchi Y; Ito M; Fukuda T
J Cutan Pathol; 1999 Mar; 26(3):145-9. PubMed ID: 10235380
[TBL] [Abstract][Full Text] [Related]
34. Papillary eccrine adenoma--a light-microscopic and immunohistochemical study.
Requena L; Peña M; Sánchez M; Sánchez Yus E
Clin Exp Dermatol; 1990 Nov; 15(6):425-8. PubMed ID: 2279339
[TBL] [Abstract][Full Text] [Related]
35. Mucinous metaplasia of apocrine duct.
Bañuls J; Ramón R; Silvestre JF; Alfonso R; Betlloch I; Botella R; Requena L
Am J Dermatopathol; 1998 Apr; 20(2):189-93. PubMed ID: 9580527
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous apocrine mixed tumor with intravascular tumor deposits: a diagnostic pitfall.
Kazakov DV; Kacerovska D; Skalova A; Zelger B; Schaller J; Shelekhova K; Michal M
Am J Dermatopathol; 2011 Dec; 33(8):775-9. PubMed ID: 21785330
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity for estrogen receptor protein in sweat gland tumors.
Swanson PE; Mazoujian G; Mills SE; Campbell RJ; Wick MR
Am J Surg Pathol; 1991 Sep; 15(9):835-41. PubMed ID: 1951842
[TBL] [Abstract][Full Text] [Related]
39. Adnexal carcinomas of the skin. I. Eccrine carcinomas.
Wick MR; Goellner JR; Wolfe JT; Su WP
Cancer; 1985 Sep; 56(5):1147-62. PubMed ID: 2990667
[TBL] [Abstract][Full Text] [Related]
40. New concepts on the histogenesis of eccrine neoplasia from keratin expression in the normal eccrine gland, syringoma and poroma.
Langbein L; Cribier B; Schirmacher P; Praetzel-Wunder S; Peltre B; Schweizer J
Br J Dermatol; 2008 Sep; 159(3):633-45. PubMed ID: 18647305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
